In 428.101(b), CMS proposes to codify the policy established in section 30.2 of the revised Medicare Part D Drug Inflation Rebate Guidance for determining the applicable threshold and excluding from the definition of a Part D rebatable drug, and thus Part D drug inflation rebates, drugs and biologicals for which the average annual total cost under Part D for such applicable period per individual who uses such drug or biological product is below that applicable threshold
Finally, Virginia is added, contributing a touch of sweetness and dark fruit to bring the blend into balance for a multidimensional smoking experience
Our total proposed burden estimate for the CY 2025 performance period/2027 MIPS payment year is 649,540 hours and $76,866,418 (see Table 77, row e), which represents a decrease of 78,366 hours and $9,000,834 from the CY 2024 PFS final rule estimate with updated wage rates and ICRs (see Table 77, row f)
Oral cancer is very aggressive due to the naturally high turn over rate of oral tissue
